Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Feisiaer Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Feisiaer Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Feisiaer Technology
Manufacturer of continuous glucose monitoring devices intended for diabetic care. The company's range of products includes wearable CGM devices, non-invasive sensors, real-time alert systems, glucose trend analytics and calibration-free monitoring units, thereby enabling more accessible, accurate and user-friendly diabetes management.
- Sector
- Healthcare
- HQ
- Harbin, China
- Founded
- 2020
- Employees
- 3
- Ownership
- Privately Held (backing)
Feisiaer Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Feisiaer Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Feisiaer Technology in its N-PORT filings yet. We sweep new filings monthly.